Investment Rating - The report maintains an "Add" investment rating for the company [2][7]. Core Insights - The company's G-end business has established a solid customer base in grassroots medical institutions, with further penetration potential at the county level, supported by national policy needs, which is expected to sustain robust growth [6][7]. - The B/C-end business is experiencing significant growth, leveraging the technological barriers of the Spark Medical large model, with flagship smart hospital solutions being implemented in major hospitals like West China Hospital, which is anticipated to expand the hospital client base further [6][7]. - The AI post-diagnosis patient management has made breakthroughs in six provinces, alongside growing demand for imaging cloud and medical devices, contributing to revenue growth and sustainability [6][7]. Financial Performance - For the fiscal year 2024, the company achieved revenue of 734 million yuan, a year-on-year increase of 32.0%, with a gross profit of 404 million yuan and a gross margin of 55.1% [6][8]. - The company reported a net loss attributable to shareholders of 133 million yuan, an improvement from a loss of 145 million yuan in the previous year [6][8]. - Revenue from G-end services, hospital services, regional management platform solutions, and patient services reached 237 million, 132 million, 154 million, and 211 million yuan respectively, with notable growth in B-end services [6][8]. Revenue Forecast - The company forecasts revenues of 1.037 billion, 1.441 billion, and 1.922 billion yuan for the years 2025, 2026, and 2027, representing year-on-year growth rates of 41%, 39%, and 33% respectively [7][8]. Key Financial Ratios - The company’s return on equity (ROE) for 2024 is projected at -14.1%, with a gradual improvement expected in subsequent years [10]. - The asset-liability ratio is expected to be 52.8% in 2024, indicating a stable financial structure [10]. Major Shareholders - The primary shareholder is iFlytek Co., Ltd., holding a 24.71% stake in the company [2].

Investment Rating - The investment rating for the company is "Buy" [2][8] Core Insights - The company is experiencing strong brand momentum, maintaining high growth in store openings, and continuously optimizing profitability [3][8] - The 2024 performance slightly exceeded expectations, with adjusted net profit forecasts for 2025 and 2026 raised to 185 million and 278 million RMB respectively, and a new forecast for 2027 set at 368 million RMB [8] Financial Summary - Revenue for 2024 is projected at 4.314 billion RMB, representing a year-on-year increase of 41.4% [7][8] - The operating profit from stores is expected to reach 624 million RMB, with a year-on-year growth of 48.7% and a store operating profit margin of 14.5%, up 0.7 percentage points [8] - The adjusted net profit for 2024 is forecasted at 1.31 billion RMB, a significant increase of 1394.2% year-on-year, with an adjusted net profit margin of 3.04%, up 2.75 percentage points [8] - The company plans to open approximately 300 new stores in 2025, with a capital expenditure of about 570 million RMB [8] Store Expansion and Sales Performance - The total number of stores is expected to reach 1,008 by the end of 2024, reflecting a year-on-year increase of 31.25% [8] - Same-store sales growth for 2024 is projected at 2.5%, with a daily average sales per store of 13,100 RMB, an increase of 4.3% year-on-year [8] - The average payback period for new stores opened in 2024 is estimated at 12 months [8] Profitability and Cost Structure - The gross profit margin for 2024 is expected to be 72.88%, an increase of 0.31 percentage points year-on-year [8] - Employee costs as a percentage of revenue decreased to 34.99%, down 3.65 percentage points year-on-year [8] - Advertising and promotion expenses accounted for 5.04% of revenue, a decrease of 0.17 percentage points year-on-year [8]

证券研究报告|港股公司点评报告 [Table_Date] 2025 年 03 月 29 日 [Table_Title] 剔除减值影响业绩符合预期，派息率新高 [Table_Title2] 李宁(2331.HK) | [Table_DataInfo] 评级： | 买入 | 股票代码： | 2331 | | --- | --- | --- | --- | | 上次评级： | 买入 | 52 周最高价/最低价(港 | 24.05/13.02 | | | | 元)： | | | 目标价格(港元)： | | 总市值(亿港元) | 443.55 | | 最新收盘价(港元)： | 17.16 | 自由流通市值(亿港元) | 443.55 | | | | 自由流通股数(百万) | 2,584.80 | [Table_Summary] 事件概述 2024年公司实现收入/归母净利/EBITDA/经营现金流为286.76/30.13/63.79/52.68亿元、同比增长3.9%/- 5.5%/3.6%/12.4%。我们分析，剔除投资性房地产减值3.3亿影响后的归母净利为33.43亿元，符合市场预期； 剔除投资性其他收入、权益法入账 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [3][9] Core Insights - The company reported a revenue of 9.11 billion yuan for 2024, representing a year-over-year growth of 16.5%. The net profit attributable to shareholders was 2.09 billion yuan, with a year-over-year increase of 34.9% [4][6] - The company is expected to achieve revenues of 10.20 billion yuan, 11.49 billion yuan, and 13.15 billion yuan for 2025, 2026, and 2027 respectively, with growth rates of 12%, 13%, and 14% [6][8] - The adjusted net profit for 2024 was 2.32 billion yuan, exceeding expectations with a year-over-year growth of 18.8% [4][6] Financial Performance Summary - The company’s total revenue for 2023 was 7.84 billion yuan, with a growth rate of 14% year-over-year [3] - The net profit attributable to shareholders for 2023 was 1.55 billion yuan, showing a decline of 19% year-over-year [3] - Earnings per share (EPS) for 2023 was 0.65 yuan, projected to increase to 0.87 yuan in 2024 and further to 1.26 yuan by 2027 [3][8] Pipeline and Market Potential - The company has several upcoming product approvals, including a license-in product for gastric cancer and new indications for existing drugs, which are expected to drive future growth [6] - The company is focusing on expanding its international market presence, particularly with its dual-antibody products [6]

计算机/软件开发 公 司 研 究 明源云（00909.HK） 待地产企稳驱动收入回升，AI 规划积极提供估值弹 2025 年 03 月 29 日 投资评级：买入（维持） | 日期 | 2025/3/28 | | --- | --- | | 当前股价(港元) | 3.050 | | 一年最高最低(港元) | 4.650/1.570 | | 总市值(亿港元) | 59.29 | | 流通市值(亿港元) | 58.91 | | 总股本(亿股) | 19.44 | | 流通港股(亿股) | 19.32 | | 近 3 个月换手率(%) | 69.71 | 公 司 信 息 更 新 报 告 股价走势图 数据来源：聚源 -60% -30% 0% 30% 60% 90% 120% 2024-04 2024-08 2024-12 明源云 恒生指数 相关研究报告 | 吴柳燕（分析师） | 杨哲（分析师） | | --- | --- | | wuliuyan@kysec.cn | yangzhe@kysec.cn | | 证书编号：S0790521110001 | 证书编号：S0790524100001 | 证书编号：S07905 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a significant improvement across all business lines in Q4, with a year-on-year net profit growth exceeding 80% [1] - The total revenue for 2024 is projected to be 33.172 billion yuan, a decrease of 6.42% compared to the previous year, while the net profit is expected to be 5.694 billion yuan, down 7.5% year-on-year [1] - The company has a strong competitive position in investment banking and wealth management, with expectations of further leveraging its leading advantages as market activity and conditions improve [1] Financial Performance Summary - Total revenue for 2023 was 35.446 billion yuan, with a year-on-year decline of 5.22% [1] - The net profit for 2023 was 6.156 billion yuan, reflecting an 18.97% decrease year-on-year [1] - The earnings per share (EPS) for 2023 was 1.28 yuan, with a projected EPS of 1.04 yuan for 2024 [1] - The company achieved a net income of 28.4 billion yuan in Q4 2024, marking an 83.2% increase year-on-year [1] Business Segment Performance - Brokerage income for 2024 is expected to be 4.26 billion yuan, down 5.9% year-on-year, but Q4 saw a significant increase of 67.6% [1] - Investment banking revenue for 2024 is projected at 3.09 billion yuan, a decrease of 16.4% year-on-year, with a notable drop in equity underwriting [1] - Asset management revenue for 2024 is expected to be 1.21 billion yuan, a slight decrease of 0.3% year-on-year [1] - The company reported a significant recovery in proprietary trading, with Q4 investment income reaching 4.35 billion yuan, up 51% year-on-year [1]

Investment Rating - The investment rating for the company is "Increase" [2][4] Core Views - The company is experiencing a decline in revenue due to a sluggish real estate market, with a projected revenue of 1.38 billion in 2025, down from 1.43 billion in 2024, reflecting a decrease of 4% [2][4] - The adjusted net profit is expected to improve significantly, moving from a loss of 190 million in 2024 to a profit of 30 million in 2025, indicating a growth rate of 85% [2][4] - The company is focusing on enhancing its SaaS products through AI technology and expanding its presence in overseas markets, which is expected to create new growth opportunities [3][4] Financial Forecasts - Revenue projections for 2025, 2026, and 2027 are 1.38 billion, 1.43 billion, and 1.55 billion respectively, with growth rates of -4%, 3%, and 9% [2][4] - The company anticipates a net profit of -28 million in 2025, followed by a profit of 30 million in 2026 and 123 million in 2027, showing a significant recovery trajectory [2][4] - The earnings per share (EPS) is expected to improve from -0.10 in 2024 to 0.06 in 2027 [2][4] Business Strategy - The company is shifting its focus towards asset management and operations in the real estate sector, which is expected to yield positive results despite the overall market downturn [3][4] - The introduction of AI-driven products is aimed at enhancing marketing capabilities in the real estate sector, with significant contracts already signed with major developers [3][4] - The company is actively expanding its international market presence, particularly in regions like Japan, Hong Kong, and Southeast Asia, to tap into diverse real estate opportunities [3][4]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Insights - The company experienced a significant improvement across all business lines in Q4, with a year-on-year net profit growth exceeding 80% [1] - The total revenue for 2024 is projected to be 331.72 billion yuan, a decrease of 6.4% year-on-year, while the net profit is expected to be 56.94 billion yuan, down 7.5% year-on-year [7] - The brokerage business saw a slight decline in revenue for the year, but a substantial increase in Q4, with net income reaching 17 billion yuan, up 67.6% year-on-year [7] - The investment banking segment remains strong, with net income of 30.9 billion yuan, despite a 16.4% year-on-year decline [7] - Asset management revenue was 12.1 billion yuan, a slight decrease of 0.3% year-on-year, with total assets under management at 552 billion yuan [7] - The company’s self-operated investment income showed a significant recovery in Q4, with investment income of 43.5 billion yuan, up 51% year-on-year [7] - The report projects an increase in net profit for 2025 and 2026, estimating 66.21 billion yuan and 70.69 billion yuan respectively, with growth rates of 16% and 7% [7] Financial Summary - Total revenue for 2023 was 35,446 million yuan, with a forecasted decrease to 33,172 million yuan in 2024 [1] - The company’s earnings per share (EPS) for 2024 is projected at 1.04 yuan, with a price-to-earnings (P/E) ratio of 13.29 [1] - The company’s total assets are expected to reach 674,716 million yuan in 2024, with a debt-to-asset ratio of 83.35% [6][13]

Investment Rating - The report maintains a "Buy" rating for China Resources Vientiane Life (01209.HK) with a target price of HKD 39.04 [2][8] Core Views - The company achieved a revenue of approximately HKD 17.043 billion in 2024, representing a year-on-year growth of 15.4%. The net profit attributable to shareholders was HKD 3.629 billion, up 23.9% year-on-year, while the core net profit attributable to shareholders was about HKD 3.507 billion, increasing by 20.1% year-on-year. The gross margin improved to 32.9%, an increase of 1.1 percentage points year-on-year [2][4] Financial Performance Summary - **Revenue Growth**: The total revenue for 2024 is projected at HKD 17.043 billion, with expected growth rates of 15% in 2025, 12% in 2026, and 12% in 2027 [4] - **Net Profit**: The net profit attributable to shareholders is forecasted to be HKD 3.629 billion in 2024, with growth rates of 24% in 2025, 15% in 2026, and 15% in 2027 [4] - **Earnings Per Share (EPS)**: EPS is expected to be HKD 1.59 in 2024, increasing to HKD 1.82 in 2025, HKD 2.08 in 2026, and HKD 2.39 in 2027 [4] - **Valuation Ratios**: The price-to-earnings (P/E) ratio is projected to be 20 in 2024, decreasing to 14 by 2027, while the price-to-book (P/B) ratio remains stable at 4 for 2024 and 2025, and drops to 3 in 2026 and 2027 [4] Business Segment Performance - **Shopping Centers**: Revenue from shopping centers reached HKD 4.209 billion in 2024, a year-on-year increase of 30%, with a gross margin of 72.6%. The retail sales in managed shopping centers grew by 18.7% year-on-year [8] - **Property Management**: The property management segment generated revenue of HKD 10.715 billion, up 11.6% year-on-year, although the overall gross margin slightly decreased to 17.0% [8] - **Office Buildings**: Revenue from office buildings was HKD 2.065 billion, reflecting a 7.1% year-on-year increase, with a gross margin of 34.9% [8] Dividend Policy - The company has maintained a 100% payout ratio for core net profit attributable to shareholders for two consecutive years, with total dividends per share reaching HKD 1.536, resulting in a dividend yield of approximately 5% based on the closing price on March 27 [8]

社会服务/酒店餐饮 特海国际（09658.HK） 经营效率提升亮眼，关注多元品牌孵化和北美拓展 2025 年 03 月 29 日 投资评级：买入（维持） | 日期 | 2025/3/28 | | --- | --- | | 当前股价(港元) | 17.800 | | 一年最高最低(港元) | 24.100/10.940 | | 总市值(亿港元) | 115.75 | | 流通市值(亿港元) | 115.75 | | 总股本(亿股) | 6.50 | | 流通港股(亿股) | 6.50 | | 近 3 个月换手率(%) | 10.73 | 股价走势图 -40% -20% 0% 20% 40% 60% 80% 2024-04 2024-08 2024-12 特海国际 恒生指数 数据来源：聚源 相关研究报告 《翻台显著增长，换帅后期待开店和 多品牌拓展加速—公司信息更新报 告》-2024.9.1 《经营业绩亮眼，提质增效多区域本 土化成果显著—公司信息更新报告》 -2024.3.29 东亚、北美增长亮眼，东南亚基本盘稳固 分地区看，截至 2024 年底东南亚、东亚、北美、其他餐厅数量分别为 73/19/20/10， ...